Rethinking the Brain: Metabolism, Psychiatry, and Hope with Dr. Christopher M. Palmer

In this powerful episode of Collegial Conversations, host Diana Clark sits down with Harvard psychiatrist Dr. Christopher Palmer to explore a groundbreaking shift in how we understand and treat mental health. Drawing from deeply personal experiences and decades of clinical work, Dr. Palmer explains how metabolic dysfunction in the brain may be at the root of conditions like schizophrenia, bipolar disorder, and depression. He shares compelling patient stories—including cases of long-term remission—and discusses the emerging science behind ketogenic therapy as a psychiatric treatment. This conversation challenges traditional boundaries between mind and body, offering both scientific insight and renewed hope for individuals and families navigating severe mental illness. Meet Dr. Christopher M. Palmer Dr. Christopher M. Palmer is a Harvard-trained psychiatrist, author, and pioneering researcher working at the intersection of metabolism and mental health. He serves as an Assistant Professor of Psychiatry at Harvard Medical School and has spent over 30 years in clinical, research, and leadership roles at McLean Hospital. Dr. Palmer is the Founder and Director of the Metabolic and Mental Health Program and the founder of MH2, a multidisciplinary practice dedicated to treating mental illness through both conventional and metabolic approaches. He is widely recognized for advancing the theory that mental disorders are fundamentally metabolic disorders of the brain. His work—particularly on the use of the ketogenic diet in psychiatry—has gained international attention and is helping shape a new frontier in mental health treatment. 🌐 Learn more: https://www.chrispalmermd.com https://mh2.health https://brainenergy.com/ For more information, visit us at www.intentclinical.com